LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 25

Search options

  1. Article ; Online: Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.

    Ilieva, Hristelina / Vullaganti, Mithila / Kwan, Justin

    BMJ (Clinical research ed.)

    2023  Volume 383, Page(s) e075037

    Abstract: Although the past two decades have produced exciting discoveries in the genetics and pathology of amyotrophic lateral sclerosis (ALS), progress in developing an effective therapy remains slow. This review summarizes the critical discoveries and outlines ... ...

    Abstract Although the past two decades have produced exciting discoveries in the genetics and pathology of amyotrophic lateral sclerosis (ALS), progress in developing an effective therapy remains slow. This review summarizes the critical discoveries and outlines the advances in disease characterization, diagnosis, imaging, and biomarkers, along with the current status of approaches to ALS care and treatment. Additional knowledge of the factors driving disease progression and heterogeneity will hopefully soon transform the care for patients with ALS into an individualized, multi-prong approach able to prevent disease progression sufficiently to allow for a dignified life with limited disability.
    MeSH term(s) Humans ; Amyotrophic Lateral Sclerosis/diagnosis ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/therapy ; Pathology, Molecular ; Disease Progression
    Language English
    Publishing date 2023-10-27
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj-2023-075037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Valproic acid and zonisamide induced hyperammonemic encephalopathy.

    Ilieva, Hristelina S / Newman, Joseph W / Fields, Ronald K / Croom, John E

    Clinical neurology and neurosurgery

    2020  Volume 196, Page(s) 105894

    MeSH term(s) Adult ; Anticonvulsants/adverse effects ; Brain/diagnostic imaging ; Brain Diseases/chemically induced ; Brain Diseases/diagnostic imaging ; Epilepsy/drug therapy ; Humans ; Hyperammonemia/chemically induced ; Hyperammonemia/diagnostic imaging ; Magnetic Resonance Imaging ; Male ; Valproic Acid/adverse effects ; Zonisamide/adverse effects
    Chemical Substances Anticonvulsants ; Zonisamide (459384H98V) ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2020-05-15
    Publishing country Netherlands
    Document type Case Reports ; Journal Article
    ZDB-ID 193107-6
    ISSN 1872-6968 ; 0303-8467
    ISSN (online) 1872-6968
    ISSN 0303-8467
    DOI 10.1016/j.clineuro.2020.105894
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Motoneuron Disease: Clinical.

    Ilieva, Hristelina / Maragakis, Nicholas J

    Advances in neurobiology

    2017  Volume 15, Page(s) 191–210

    Abstract: ALS is a neurodegenerative disease in which the primary symptoms result in progressive neuromuscular weakness. Recent studies have highlighted that there is significant heterogeneity with regard to anatomical and temporal disease progression. Importantly, ...

    Abstract ALS is a neurodegenerative disease in which the primary symptoms result in progressive neuromuscular weakness. Recent studies have highlighted that there is significant heterogeneity with regard to anatomical and temporal disease progression. Importantly, more recent advances in genetics have revealed new causative genes to the disease. New efforts have focused on the development of biomarkers that could aid in diagnosis, prognosis, and serve as pharmacodynamics markers. Although traditional pharmaceuticals continue to undergo trials for ALS, new therapeutic strategies including stem cell transplantation studies, gene therapies, and antisense therapies targeting some of the familial forms of ALS are gaining momentum.
    MeSH term(s) Amyotrophic Lateral Sclerosis/physiopathology ; Amyotrophic Lateral Sclerosis/therapy ; Disease Progression ; Exercise Therapy ; Frontotemporal Dementia/physiopathology ; Frontotemporal Dementia/therapy ; Genetic Therapy ; Humans ; Motor Neuron Disease/physiopathology ; Motor Neuron Disease/therapy ; Neuroprotective Agents/therapeutic use ; Noninvasive Ventilation ; Nutritional Support ; Oligonucleotides, Antisense/therapeutic use ; Phenotype ; Riluzole/therapeutic use ; Stem Cell Transplantation
    Chemical Substances Neuroprotective Agents ; Oligonucleotides, Antisense ; Riluzole (7LJ087RS6F)
    Language English
    Publishing date 2017-07-03
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2190-5215
    ISSN 2190-5215
    DOI 10.1007/978-3-319-57193-5_7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Motoneuron Disease: Basic Science.

    Ilieva, Hristelina / Maragakis, Nicholas J

    Advances in neurobiology

    2017  Volume 15, Page(s) 163–190

    Abstract: ALS is a relentless neurodegenerative disease in which motor neurons are the susceptible neuronal population. Their death results in progressive paresis of voluntary and respiratory muscles. The unprecedented rate of discoveries over the last two decades ...

    Abstract ALS is a relentless neurodegenerative disease in which motor neurons are the susceptible neuronal population. Their death results in progressive paresis of voluntary and respiratory muscles. The unprecedented rate of discoveries over the last two decades have broadened our knowledge of genetic causes and helped delineate molecular pathways. Here we critically review ALS epidemiology, genetics, pathogenic mechanisms, available animal models, and iPS cell technologies with a focus on their translational therapeutic potential. Despite limited clinical success in treatments to date, the new discoveries detailed here offer new models for uncovering disease mechanisms as well as novel strategies for intervention.
    MeSH term(s) Amyotrophic Lateral Sclerosis/epidemiology ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/physiopathology ; Animals ; C9orf72 Protein/genetics ; Cell Cycle Proteins/genetics ; DNA-Binding Proteins/genetics ; Disease Models, Animal ; Frontotemporal Dementia/epidemiology ; Frontotemporal Dementia/genetics ; Frontotemporal Dementia/physiopathology ; Genes, Modifier/genetics ; Humans ; Induced Pluripotent Stem Cells ; Motor Neuron Disease/epidemiology ; Motor Neuron Disease/genetics ; Motor Neuron Disease/physiopathology ; RNA-Binding Protein FUS/genetics ; Superoxide Dismutase-1/genetics ; Translational Medical Research ; Ubiquitins/genetics
    Chemical Substances C9orf72 Protein ; Cell Cycle Proteins ; DNA-Binding Proteins ; RNA-Binding Protein FUS ; TARDBP protein, human ; UBQLN2 protein, human ; Ubiquitins ; Superoxide Dismutase-1 (EC 1.15.1.1)
    Language English
    Publishing date 2017-07-03
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2190-5215
    ISSN 2190-5215
    DOI 10.1007/978-3-319-57193-5_6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients.

    Pinilla, Gabriel / Kumar, Anupama / Floaters, Mary Kay / Pardo, Carlos A / Rothstein, Jeffrey / Ilieva, Hristelina

    Amyotrophic lateral sclerosis & frontotemporal degeneration

    2021  Volume 22, Issue 7-8, Page(s) 517–527

    Abstract: C9ORF72 hexanucleotide expansion is the most common genetic cause of familial amyotrophic lateral sclerosis (ALS)/fronto-temporal dementia (FTD) disease spectrum. Even though three major mechanisms of disease pathogenesis have been proposed, we lack ... ...

    Abstract C9ORF72 hexanucleotide expansion is the most common genetic cause of familial amyotrophic lateral sclerosis (ALS)/fronto-temporal dementia (FTD) disease spectrum. Even though three major mechanisms of disease pathogenesis have been proposed, we lack detailed understanding of the factors that influence disease onset and progression. We sought to characterize cerebrospinal fluid and sera of C9ORF72 patients via a multiplex assay of 41 chemokines and cytokines in comparison to neurological controls and sporadic ALS patients. We found an increase in synthesis of pro-inflammatory chemokines and cytokines in disease samples and particularly in C9ORF72 patients in comparison to controls. We provide evidence that a CSF pro-inflammatory signature is a feature of C9ORF72-mediated disease.
    MeSH term(s) Amyotrophic Lateral Sclerosis/genetics ; C9orf72 Protein/genetics ; Cytokines/genetics ; DNA Repeat Expansion ; Frontotemporal Dementia/genetics ; Humans
    Chemical Substances C9orf72 Protein ; C9orf72 protein, human ; Cytokines
    Language English
    Publishing date 2021-04-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2705049-X
    ISSN 2167-9223 ; 2167-8421
    ISSN (online) 2167-9223
    ISSN 2167-8421
    DOI 10.1080/21678421.2021.1912100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis-linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice.

    Jensen, Brigid K / McAvoy, Kevin J / Heinsinger, Nicolette M / Lepore, Angelo C / Ilieva, Hristelina / Haeusler, Aaron R / Trotti, Davide / Pasinelli, Piera

    Glia

    2022  Volume 70, Issue 7, Page(s) 1426–1449

    Abstract: Genetic mutations that cause amyotrophic lateral sclerosis (ALS), a progressively lethal motor neuron disease, are commonly found in ubiquitously expressed genes. In addition to direct defects within motor neurons, growing evidence suggests that ... ...

    Abstract Genetic mutations that cause amyotrophic lateral sclerosis (ALS), a progressively lethal motor neuron disease, are commonly found in ubiquitously expressed genes. In addition to direct defects within motor neurons, growing evidence suggests that dysfunction of non-neuronal cells is also an important driver of disease. Previously, we demonstrated that mutations in DNA/RNA binding protein fused in sarcoma (FUS) induce neurotoxic phenotypes in astrocytes in vitro, via activation of the NF-κB pathway and release of pro-inflammatory cytokine TNFα. Here, we developed an intraspinal cord injection model to test whether astrocyte-specific expression of ALS-causative FUS
    MeSH term(s) Amyotrophic Lateral Sclerosis/pathology ; Animals ; Astrocytes/metabolism ; DNA-Binding Proteins/metabolism ; Mice ; Motor Neurons/pathology ; Sarcoma/metabolism ; Sarcoma/pathology ; Tumor Necrosis Factor-alpha/metabolism
    Chemical Substances DNA-Binding Proteins ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2022-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 639414-0
    ISSN 1098-1136 ; 0894-1491
    ISSN (online) 1098-1136
    ISSN 0894-1491
    DOI 10.1002/glia.24183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS.

    Watanabe, Seiji / Ilieva, Hristelina / Tamada, Hiromi / Nomura, Hanae / Komine, Okiru / Endo, Fumito / Jin, Shijie / Mancias, Pedro / Kiyama, Hiroshi / Yamanaka, Koji

    EMBO molecular medicine

    2016  Volume 8, Issue 12, Page(s) 1421–1437

    Abstract: A homozygous mutation in the gene for sigma 1 receptor (Sig1R) is a cause of inherited juvenile amyotrophic lateral sclerosis (ALS16). Sig1R localizes to the mitochondria-associated membrane (MAM), which is an interface of mitochondria and endoplasmic ... ...

    Abstract A homozygous mutation in the gene for sigma 1 receptor (Sig1R) is a cause of inherited juvenile amyotrophic lateral sclerosis (ALS16). Sig1R localizes to the mitochondria-associated membrane (MAM), which is an interface of mitochondria and endoplasmic reticulum. However, the role of the MAM in ALS is not fully elucidated. Here, we identified a homozygous p.L95fs mutation of Sig1R as a novel cause of ALS16. ALS-linked Sig1R variants were unstable and incapable of binding to inositol 1,4,5-triphosphate receptor type 3 (IP
    MeSH term(s) Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/pathology ; Animals ; Child ; Endoplasmic Reticulum/physiology ; Female ; Humans ; Mice ; Mitochondrial Membranes/physiology ; Receptors, sigma/genetics ; Superoxide Dismutase-1/genetics ; Sigma-1 Receptor
    Chemical Substances Receptors, sigma ; Sod1 protein, mouse (EC 1.15.1.1) ; Superoxide Dismutase-1 (EC 1.15.1.1)
    Language English
    Publishing date 2016-12-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2467145-9
    ISSN 1757-4684 ; 1757-4676
    ISSN (online) 1757-4684
    ISSN 1757-4676
    DOI 10.15252/emmm.201606403
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mitochondria‐associated membrane collapse is a common pathomechanism in SIGMAR1‐ and SOD1‐linked ALS

    Seiji Watanabe / Hristelina Ilieva / Hiromi Tamada / Hanae Nomura / Okiru Komine / Fumito Endo / Shijie Jin / Pedro Mancias / Hiroshi Kiyama / Koji Yamanaka

    EMBO Molecular Medicine, Vol 8, Iss 12, Pp 1421-

    2016  Volume 1437

    Abstract: Abstract A homozygous mutation in the gene for sigma 1 receptor (Sig1R) is a cause of inherited juvenile amyotrophic lateral sclerosis (ALS16). Sig1R localizes to the mitochondria‐associated membrane (MAM), which is an interface of mitochondria and ... ...

    Abstract Abstract A homozygous mutation in the gene for sigma 1 receptor (Sig1R) is a cause of inherited juvenile amyotrophic lateral sclerosis (ALS16). Sig1R localizes to the mitochondria‐associated membrane (MAM), which is an interface of mitochondria and endoplasmic reticulum. However, the role of the MAM in ALS is not fully elucidated. Here, we identified a homozygous p.L95fs mutation of Sig1R as a novel cause of ALS16. ALS‐linked Sig1R variants were unstable and incapable of binding to inositol 1,4,5‐triphosphate receptor type 3 (IP3R3). The onset of mutant Cu/Zn superoxide dismutase (SOD1)‐mediated ALS disease in mice was accelerated when Sig1R was deficient. Moreover, either deficiency of Sig1R or accumulation of mutant SOD1 induced MAM disruption, resulting in mislocalization of IP3R3 from the MAM, calpain activation, and mitochondrial dysfunction. Our findings indicate that a loss of Sig1R function is causative for ALS16, and collapse of the MAM is a common pathomechanism in both Sig1R‐ and SOD1‐linked ALS. Furthermore, our discovery of the selective enrichment of IP3R3 in motor neurons suggests that integrity of the MAM is crucial for the selective vulnerability in ALS.
    Keywords amyotrophic lateral sclerosis ; inositol 1,4,5‐triphosphate receptor type 3 ; mitochondria‐associated membrane ; sigma 1 receptor ; Medicine (General) ; R5-920 ; Genetics ; QH426-470
    Language English
    Publishing date 2016-12-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

    Ilieva, Hristelina / Polymenidou, Magdalini / Cleveland, Don W

    The Journal of cell biology

    2009  Volume 187, Issue 6, Page(s) 761–772

    Abstract: Selective degeneration and death of one or more classes of neurons is the defining feature of human neurodegenerative disease. Although traditionally viewed as diseases mainly affecting the most vulnerable neurons, in most instances of inherited disease ... ...

    Abstract Selective degeneration and death of one or more classes of neurons is the defining feature of human neurodegenerative disease. Although traditionally viewed as diseases mainly affecting the most vulnerable neurons, in most instances of inherited disease the causative genes are widely-usually ubiquitously-expressed. Focusing on amyotrophic lateral sclerosis (ALS), especially disease caused by dominant mutations in Cu/Zn superoxide dismutase (SOD1), we review here the evidence that it is the convergence of damage developed within multiple cell types, including within neighboring nonneuronal supporting cells, which is crucial to neuronal dysfunction. Damage to a specific set of key partner cells as well as to vulnerable neurons may account for the selective susceptibility of neuronal subtypes in many human neurodegenerative diseases, including Huntington's disease (HD), Parkinson's disease (PD), prion disease, the spinal cerebellar ataxias (SCAs), and Alzheimer's disease (AD).
    MeSH term(s) Amyotrophic Lateral Sclerosis/enzymology ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/pathology ; Animals ; Astrocytes/enzymology ; Astrocytes/pathology ; Axonal Transport ; Capillaries/enzymology ; Capillaries/pathology ; Cell Death ; Endoplasmic Reticulum/enzymology ; Endoplasmic Reticulum/pathology ; Glutamic Acid/metabolism ; Humans ; Microglia/enzymology ; Microglia/pathology ; Mutation ; Nerve Degeneration/enzymology ; Nerve Degeneration/genetics ; Nerve Degeneration/pathology ; Neurons/enzymology ; Neurons/pathology ; Stress, Physiological ; Superoxide Dismutase/genetics ; Superoxide Dismutase/metabolism ; Superoxide Dismutase-1 ; Superoxides/metabolism ; T-Lymphocytes/enzymology ; T-Lymphocytes/pathology
    Chemical Substances SOD1 protein, human ; Superoxides (11062-77-4) ; Glutamic Acid (3KX376GY7L) ; Superoxide Dismutase (EC 1.15.1.1) ; Superoxide Dismutase-1 (EC 1.15.1.1)
    Language English
    Publishing date 2009-12-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 218154-x
    ISSN 1540-8140 ; 0021-9525
    ISSN (online) 1540-8140
    ISSN 0021-9525
    DOI 10.1083/jcb.200908164
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

    Ilieva, Hristelina / Polymenidou, Magdalini / Cleveland, Don W

    Journal of cell biology. 2009, v. 187, no. 6

    2009  

    Abstract: Selective degeneration and death of one or more classes of neurons is the defining feature of human neurodegenerative disease. Although traditionally viewed as diseases mainly affecting the most vulnerable neurons, in most instances of inherited disease ... ...

    Abstract Selective degeneration and death of one or more classes of neurons is the defining feature of human neurodegenerative disease. Although traditionally viewed as diseases mainly affecting the most vulnerable neurons, in most instances of inherited disease the causative genes are widely--usually ubiquitously--expressed. Focusing on amyotrophic lateral sclerosis (ALS), especially disease caused by dominant mutations in Cu/Zn superoxide dismutase (SOD1), we review here the evidence that it is the convergence of damage developed within multiple cell types, including within neighboring nonneuronal supporting cells, which is crucial to neuronal dysfunction. Damage to a specific set of key partner cells as well as to vulnerable neurons may account for the selective susceptibility of neuronal subtypes in many human neurodegenerative diseases, including Huntington's disease (HD), Parkinson's disease (PD), prion disease, the spinal cerebellar ataxias (SCAs), and Alzheimer's disease (AD).
    Language English
    Size p. 761-772.
    Publishing place The Rockefeller University Press
    Document type Article
    ZDB-ID 218154-x
    ISSN 1540-8140 ; 0021-9525
    ISSN (online) 1540-8140
    ISSN 0021-9525
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top